SWOG Update
August 5, 2009
Contents  
Welcome to edition #1 of the SWOG Update.

For all members and friends of the Southwest Oncology Group, the SWOG Update will keep you informed of what's happening with the Group. News to report? Send it to communications@swog.org.

 
Chair's Corner  
Why we do what we do
Laurence H. Baker photo Our mission is straightforward: to make progress in the prevention and cure of cancer through clinical research. Our research objectives define how we work to accomplish our mission. [more]

Study Updates  

S0500: Counting CTCs to evaluate breast cancer treatment
How effective of a barometer is CTC level in measuring the efficacy of treatment in a clinical setting, and can that measurement be used to extend lives? [more]

cetuximab molecule S0819 adds a new drug to a standard lung cancer therapy
SWOG's newest study will compare outcomes for lung cancer patients given an accepted standard treatment to outcomes for patients given the same treatment plus cetuximab. [more]

 
In the News  
You, your colleagues, and your cooperative group in the media ...
Share |

Did you know . . . ?

Annual accrual to SWOG-sponsored treatment trials increased by 36% from 2006 to 2008, climbing from 3,920 to 5,337. Current projections for 2009 show accrual surpassing the 6,000 mark.

SWOG accrual graph from 2004 (4,542) to 2009 projected (6,552)
Source: SWOG site visit presentation to NIH, July 2009

Got news to tell? Send it to communications@swog.org.